Compound amino acid injection and preparation method thereof
A compound amino acid and injection technology, applied in the field of biomedicine, can solve the problems of poor solution stability and slow release effect, and achieve the effects of improving the utilization rate and reducing the number of injections
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] A compound amino acid injection, in parts by weight, comprising the following components: 1 part of lysine acetate, 0.5 part of methionine, 0.5 part of phenylalanine, 0.2 part of threonine, 0.4 part of alanine, 0.4 part of arginine, 0.03 part of aspartic acid, 0.07 part of glutamic acid, 0.7 part of histidine, 0.6 part of proline, 0.3 part of serine, 0.15 part of tyrosine, 0.5 part of glycine, 0.07 part of cysteine parts, 180 parts of water for injection, and 5 parts of the polylactic acid-modified fronthu-chitosan quaternary ammonium salt complex containing isoleucine, leucine, tryptophan and valine.
[0033]The preparation method of the polylactic acid-modified fronthu-chitosan quaternary ammonium salt compound comprising isoleucine, leucine, tryptophan and valine is as follows:
[0034] Wherein, the mass ratio of isoleucine, leucine, tryptophan, valine, polylactic acid, modified Qianhu and chitosan quaternary ammonium salt in the complex is 0.5:1:0.05:0.5 :3:5:4.
...
Embodiment 2
[0043] A compound amino acid injection, in parts by weight, comprising the following components: 1.5 parts of lysine acetate, 1.0 parts of methionine, 1.0 parts of phenylalanine, 0.6 parts of threonine, 0.6 parts of alanine, 0.6 part of arginine, 0.05 part of aspartic acid, 0.05 part of glutamic acid, 0.5 part of histidine, 0.4 part of proline, 0.2 part of serine, 0.1 part of tyrosine, 0.3 part of glycine, 0.04 part of cysteine parts, 200 parts of water for injection, and 7 parts of the polylactic acid-modified fronthu-chitosan quaternary ammonium salt complex containing isoleucine, leucine, tryptophan, and valine.
[0044] The preparation method of the polylactic acid-modified fronthu-chitosan quaternary ammonium salt compound comprising isoleucine, leucine, tryptophan and valine is as follows:
[0045] Wherein, the mass ratio of isoleucine, leucine, tryptophan, valine, polylactic acid, modified Qianhu and chitosan quaternary ammonium salt in the complex is 0.7:1.2:0.08:0.7 ...
Embodiment 3
[0054] A compound amino acid injection, in parts by weight, comprising the following components: 2 parts of lysine acetate, 1.5 parts of methionine, 1.5 parts of phenylalanine, 1.0 parts of threonine, 0.8 parts of alanine, 0.8 part of arginine, 0.07 part of aspartic acid, 0.03 part of glutamic acid, 0.3 part of histidine, 0.2 part of proline, 0.1 part of serine, 0.05 part of tyrosine, 0.1 part of glycine, 0.03 part of cysteine parts, 220 parts of water for injection, and 10 parts of the polylactic acid-modified fronthu-chitosan quaternary ammonium salt complex containing isoleucine, leucine, tryptophan, and valine.
[0055] The preparation method of the polylactic acid-modified fronthu-chitosan quaternary ammonium salt compound comprising isoleucine, leucine, tryptophan and valine is as follows:
[0056] Wherein, the mass ratio of isoleucine, leucine, tryptophan, valine, polylactic acid, modified Qianhu and chitosan quaternary ammonium salt in the complex is 1:1.5:0.1:0.8 :5:...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com


